Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma (2014)
- Authors:
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Subjects: CÉLULAS EPITELIAIS; MELANOMA
- Language: Inglês
- Imprenta:
- Source:
- Título: Pigment Cell & Melanoma
- ISSN: 1755-1471
- Volume/Número/Paginação/Ano: v. 27, n. 6, p. 1190, 2014
- Conference titles: Society for Melanoma Research Congress
-
ABNT
FAIÃO-FLORES, Fernanda et al. Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma. Pigment Cell & Melanoma. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 24 jan. 2026. , 2014 -
APA
Faião-Flores, F., Alves, D. K., Sandri, S., & Maria-Engler, S. S. (2014). Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma. Pigment Cell & Melanoma. Hoboken: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Faião-Flores F, Alves DK, Sandri S, Maria-Engler SS. Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma. Pigment Cell & Melanoma. 2014 ; 27( 6): 1190.[citado 2026 jan. 24 ] -
Vancouver
Faião-Flores F, Alves DK, Sandri S, Maria-Engler SS. Epithelial mesenchymal transition as an alternative pathway in vemurafenib and vemurafenib/trametinib chemoresistant melanoma. Pigment Cell & Melanoma. 2014 ; 27( 6): 1190.[citado 2026 jan. 24 ] - Artepillin C induces selective oxidative stress and inhibits migration and invasion in a comprehensive panel of human cervical cancer cell lines
- Epiderme equivalente para estudos de fotoproteção in vitro
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- REPIN-1 as a tumoral marker in cervical cancer
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- Autofagia para a sobrevivência
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma
- The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies
- Novel kojic acid derivatives ACT on melanogenesis and skin age-related enzymes
- Resenha sem título próprio
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
